Research ethics during a pandemic (COVID-19)

被引：5

作者：

Yeoh, Kheng-Wei ^{[1
]}

Shah, Ketan ^{[2
]}

机构：

[1] Singapore Gen Hosp, SingHlth, Singapore 169608, Singapore

[2] Oxford Univ Hosp NHS Trust, Old Rd, Oxford OX3 7SG, England

来源：

INTERNATIONAL HEALTH | 2021年 / 13卷 / 04期

关键词：

Medical Ethics; International Health; COVID-19; Pandemic;

D O I：

10.1093/inthealth/ihaa054

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

引用

页码：374 / 375

页数：2

共 12 条

[1]

[Anonymous], 2020, STATEMENT CHIEF INVE

[2]

[Anonymous], 2020, ETH STAND RES PUBL H

[3]

[Anonymous], 2020, RES GLOB HLTH EM ETH

[4]

[Anonymous], 2020, AMA CODE MED ETHICS

[5]

[Anonymous], 2016, GUID MAN ETH ISS INF

[6]

[Anonymous], 2020, GUIDANCE NIH FUNDED

[7] Fair Allocation of Scarce Medical Resources in the Time of Covid-19 [J].

Emanuel, Ezekiel J. ;

Persad, Govind ;

Upshur, Ross ;

Thome, Beatriz ;

Parker, Michael ;

Glickman, Aaron ;

Zhang, Cathy ;

Boyle, Connor ;

Smith, Maxwell ;

Phillips, James P. .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (21) :2049-2055

[8]

FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Public Health Emergency, FDA GUIDANCE CONDUCT

[9] Chloroquine and hydroxychloroquine in covid-19 [J].

Ferner, Robin E. ;

Aronson, Jeffrey K. .

BMJ-BRITISH MEDICAL JOURNAL, 2020, 369

[10]

Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]

← 1 2 →